FDA Inspection 1205070 — Ponya Therapeutics, LLC

Ponya Therapeutics, LLC — FEI 3024253503

The FDA completed an inspection of Ponya Therapeutics, LLC on May 12, 2023 in Brookhaven, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 12, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Brookhaven, GA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
141821 CFR 211.42(c)(7)Quarantined Drug Products Area
433621 CFR 211.150Written distribution procedure